Statement of Principles concerning carpal tunnel syndrome No. 90 of 2001

Administered by Department of Veterans' Affairs

Legislation au F2006B00077 Not in force Legislative Instrument

Legislation content

Instrument No.90 of 2001

 

Revocation and Determination

of

Statement of Principles

concerning

 

CARPAL TUNNEL SYNDROME

 

ICD-10-AM CODE: G56.0

 

Veterans’ Entitlements Act 1986

 

 

1. The Repatriation Medical Authority under subsection 196B(3) of the Veterans’ Entitlements Act 1986 (the Act):

 

(a) revokes Instrument No.72 of 1997; and

 

(b) determines in its place the following Statement of Principles.

 

Kind of injury, disease or death

2. (a) This Statement of Principles is about carpal tunnel syndrome and death from carpal tunnel syndrome.

 

(b)              For the purposes of this Statement of Principles, “carpal tunnel syndrome” means an entrapment neuropathy of the median nerve at the wrist producing altered sensation, pain or weakness of the hand, attracting ICD-10-AM code G56.0.

 

Basis for determining the factors

3. On the sound medical-scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that carpal tunnel syndrome and death from carpal tunnel syndrome can be related to relevant service rendered by veterans or members of the Forces.

 

Factors that must be related to service

4. Subject to clause 6, at least one of the factors set out in clause 5 must be related to any relevant service rendered by the person.

 

Factors

5. The factors that must exist before it can be said that, on the balance of probabilities, carpal tunnel syndrome or death from carpal tunnel syndrome is connected with the circumstances of a person’s relevant service are:

 

(a)              performing any combination of repetitive activities or forceful activities with the affected hand for at least 260 hours within a period of 210 consecutive days before the clinical onset of carpal tunnel syndrome, and where the repetitive or forceful activities have not ceased more than 30 days before the clinical onset of carpal tunnel syndrome; or

 

(b)              daily self propulsion of a manual wheelchair for at least a cumulative period of 260 hours within a period of 210 consecutive days before the clinical onset of carpal tunnel syndrome, and where the self propulsion of a manual wheelchair has not ceased more than 30 days before the clinical onset of carpal tunnel syndrome; or

 

(c)              performing activities where the affected hand or forearm is directly vibrated for at least 260 hours within a period of 210 consecutive days before the clinical onset of carpal tunnel syndrome, and where those activities have not ceased more than 30 days before the clinical onset of carpal tunnel syndrome; or

 

(d)              suffering an injury to the affected wrist or hand which does not involve a fracture or a dislocation but which does:

 

(i) alter the normal contour of the carpal tunnel; or

 

(ii) damage the median nerve or flexor tendons within the carpal tunnel,

 

within the year before the clinical onset of carpal tunnel syndrome; or

 


(e)              suffering a fracture or dislocation to the lower radius, the lower ulna, a carpal bone, or a metacarpal bone of the affected side which:

 

(i) alters the normal contour of the carpal tunnel; or

 

(ii) damages the median nerve or flexor tendons within the carpal tunnel,

 

before the clinical onset of carpal tunnel syndrome; or

 

(f)               undergoing surgery to the affected wrist or hand which:

 

(i) alters the normal contour of the carpal tunnel; or

 

(ii)              damages the median nerve or flexor tendons within the carpal tunnel,

 

within the year before the clinical onset of carpal tunnel syndrome; or

 

(g)              being obese at the time of the clinical onset of carpal tunnel syndrome; or

 

(h)              undergoing haemodialysis treatment for at least the year before the clinical onset of carpal tunnel syndrome; or

 

(j)                suffering from myxoedema at the time of the clinical onset of carpal tunnel syndrome; or

 

(k)              suffering from acromegaly before the clinical onset of carpal tunnel syndrome; or

 

(m)           suffering from amyloidosis at the time of the clinical onset of carpal tunnel syndrome; or

 

(n)              suffering from gout in the affected wrist or hand at the time of the clinical onset of carpal tunnel syndrome; or

 

(o)              suffering from a space occupying lesion in the affected carpal tunnel at the time of the clinical onset of carpal tunnel syndrome; or

 

(p)              suffering from oedema involving the affected carpal tunnel at the time of the clinical onset of carpal tunnel syndrome; or

 

(q)              suffering from haemorrhage involving the affected carpal tunnel at the time of the clinical onset of carpal tunnel syndrome; or

 

(r)               suffering from infection involving the affected carpal tunnel at the time of the clinical onset of carpal tunnel syndrome; or

 

(s)               suffering from inflammatory arthritis of the affected wrist or hand at the time of the clinical onset of carpal tunnel syndrome; or

 

(t)                performing any combination of repetitive activities or forceful activities with the affected hand for at least 260 hours within a period of 210 consecutive days before the clinical worsening of carpal tunnel syndrome, and where the repetitive or forceful activities have not ceased more than 30 days before the clinical worsening of carpal tunnel syndrome; or

 

(u)              daily self propulsion of a manual wheelchair for at least a cumulative period of 260 hours within a period of 210 consecutive days before the clinical worsening of carpal tunnel syndrome, and where the self propulsion of a manual wheelchair has not ceased more than 30 days before the clinical worsening of carpal tunnel syndrome; or

 

(v)              performing activities where the affected hand or forearm is directly vibrated for at least 260 hours within a period of 210 consecutive days before the clinical worsening of carpal tunnel syndrome, and where those activities have not ceased more than 30 days before the clinical worsening of carpal tunnel syndrome; or

 

(w)            suffering an injury to the affected wrist or hand which does not involve a fracture or a dislocation but which does:

 

(i)                alter the normal contour of the carpal tunnel; or

 

(ii)             damage the median nerve or flexor tendons within the carpal tunnel,

 

within the year before the clinical worsening of carpal tunnel syndrome; or

 


(x)              suffering a fracture or dislocation to the lower radius, the lower ulna, a carpal bone, or a metacarpal bone of the affected side which:

 

(i)                alters the normal contour of the carpal tunnel; or

 

(ii)             damages the median nerve or flexor tendons within the carpal tunnel,

 

before the clinical worsening of carpal tunnel syndrome; or

 

(y)              undergoing surgery to the affected wrist or hand which:

 

(i)                alters the normal contour of the carpal tunnel; or

 

(ii)             damages the median nerve or flexor tendons within the carpal tunnel,

 

within the year before the clinical worsening of carpal tunnel syndrome; or

 

(z)              being obese at the time of the clinical worsening of carpal tunnel syndrome; or

 

(za)          undergoing haemodialysis treatment for at least the year before the clinical worsening of carpal tunnel syndrome;

 

(zb)          suffering from myxoedema at the time of the clinical worsening of carpal tunnel syndrome; or

 

(zc)          suffering from acromegaly before the clinical worsening of carpal tunnel syndrome; or

 

(zd)          suffering from amyloidosis at the time of the clinical worsening of carpal tunnel syndrome; or

 

(ze)          suffering from gout in the affected wrist or hand at the time of the clinical worsening of carpal tunnel syndrome; or

 

(zf)           suffering from a space occupying lesion in the affected carpal tunnel at the time of the clinical worsening of carpal tunnel syndrome; or

 

(zg)          suffering from oedema involving the affected carpal tunnel at the time of the clinical worsening of carpal tunnel syndrome; or

 

(zh)          suffering from haemorrhage involving the affected carpal tunnel at the time of the clinical worsening of carpal tunnel syndrome; or

 

(zi)            suffering from infection involving the affected carpal tunnel at the time of the clinical worsening of carpal tunnel syndrome; or

 

(zj)            suffering from inflammatory arthritis of the affected wrist or hand at the time of the clinical worsening of carpal tunnel syndrome; or

 

(zk)          inability to obtain appropriate clinical management for carpal tunnel syndrome.

 

Factors that apply only to material contribution or aggravation

6. Paragraphs 5(t) to 5(zk) apply only to material contribution to, or aggravation of, carpal tunnel syndrome where the person’s carpal tunnel syndrome was suffered or contracted before or during (but not arising out of) the person’s relevant service; paragraph 8(1)(e), 9(1)(e) or 70(5)(d) of the Act refers.

 

Inclusion of Statements of Principles

7. In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles.

 

Other definitions

8. For the purposes of this Statement of Principles:

 

“acromegaly” means a chronic disease of adults due to hypersecretion of the pituitary growth hormone and characterised by enlargement of many parts of the skeleton especially the distal portions, the nose, ears, jaws, fingers and toes;

 

“amyloidosis” means the accumulation of insoluble fibrillar proteins (amyloid) in organs or tissues of the body such that vital function is compromised;

 


“being obese” means an increase in body weight by way of fat accumulation which results in a Body Mass Index (BMI) of 30 or greater.

 

The BMI = W/H2 and where:

 

W is the person’s weight in kilograms and

H is the person’s height in metres;

 

“death from carpal tunnel syndrome” in relation to a person includes death from a terminal event or condition that was contributed to by the person’s carpal tunnel syndrome;

 

“forceful activities” mean:

 

(i)                tasks requiring the generation of force by the hand of more than 3 kg, or

 

(ii) holding or carrying an object in the hand greater than 1 kg in excess of ten times per hour;

 

“gout” means a metabolic condition characterised by hyperuricaemia, tissue deposition of urate crystals and clinical manifestations, which manifestations include acute inflammatory arthritis, tenosynovitis, bursitis, cellulitis, chronic erosive arthritis, or periarticular or subcutaneous urate deposits;

 

“haemodialysis treatment” means the removal of certain elements from the blood by virtue of the difference in the rates of their diffusion through a semipermeable membrane by means of a haemodialyzer;

 

“ICD-10-AM code” means a number assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, 10th revision, Australian Modification (ICD-10-AM), Second Edition, effective date of 1 July 2000, copyrighted by the National Centre for Classification in Health, Sydney, NSW, and having ISBN 1 86487 271 3;

 


“inflammatory arthritis” means one of the following diseases:

 

(i)                     rheumatoid arthritis;

(ii)                  systemic lupus erythematosus;

(iii)                systemic sclerosis (which includes circumscribed scleroderma and CREST syndrome);

(iv)                sicca syndrome (which includes keratoconjunctivitis sicca and Sjogren’s disease);

(v)                   dermatomyositis;

(vi)                polymyositis;

(vii)              eosinophilia myalgia syndrome;

(viii)           eosinophilic fasciitis;

(ix)                multifocal fibrosclerosis;

(x)                   systemic fibrosclerosing syndrome;

(xi)                unspecified diffuse connective tissue disease;

(xii)              chondrocalcinosis (also known as pseudogout);

(xiii)           arthropathy associated with Reiter’s disease and nonspecific urethritis;

(xiv)            postdysenteric arthropathy;

(xv)              psoriatic arthropathy;

(xvi)            arthropathy associated with inflammatory bowel disease;

(xvii)         ankylosing spondylitis; or

(xviii)       other inflammatory arthritis requiring treatment with methotrexate or penicillamine or azathioprine or gold;

 

“myxoedema” means a condition characterised by dry, waxy swelling of the skin and other tissues and associated with hypothyroidism;

 

“oedema” means the presence of abnormally large amounts of fluid in the intercellular tissue spaces of the body and demonstrated by accumulation of excessive fluid in the subcutaneous tissues;

 

“relevant service” means:

 

(a) eligible war service (other than operational service); or

(b)              defence service (other than hazardous service);

 

“repetitive activities” mean:

 

(i)                bending or twisting of the hand or wrist; or

(ii)              carrying out the same or similar movements in the hand or wrist;

 

at least 100 times an hour;

 


“space occupying lesion in the affected carpal tunnel” means one of the following entities occupying space within the carpal tunnel:

 

(a)              neoplasm;

(b)              aneurysm;

(c)              calcification;

(d)              cyst; or

(e)              ganglion;

 

“terminal event” means the proximate or ultimate cause of death and includes:

 

(a) pneumonia;

(b) respiratory failure;

(c) cardiac arrest;

(d) circulatory failure; or

(e)              cessation of brain function.

 

Application

9. This Instrument applies to all matters to which section 120B of the Act applies.

 

 

Dated this Twentieth day of  November 2001

 

 

The Common Seal of the    )

Repatriation Medical Authority   )

was affixed to this instrument  )

in the presence of:    )

 

KEN DONALD

CHAIRMAN

Overview

The Veterans' Entitlements Act 1986, enacted by the Australian Parliament, establishes a framework for the provision of benefits and services to Australian Defence Force (ADF) veterans, their families, and dependants. One significant legislative instrument under this Act is the Revocation and Determination of Statement of Principles concerning Carpal Tunnel Syndrome ICD-10-AM Code: G56.0, issued in 2001 by the Repatriation Medical Authority. This instrument addresses the need to clarify and determine the factors that establish a link between service-related activities and the development or worsening of carpal tunnel syndrome in veterans. The policy objective of this instrument is to ensure that veterans who suffer from carpal tunnel syndrome as a result of their service can access the necessary medical and compensation benefits. The instrument revokes a previous statement of principles and introduces new criteria that must be met to establish a connection between the syndrome and the veteran's service.

Scope and Application

This legislative instrument, being Instrument No.90 of 2001, revokes Instrument No.72 of 1997 and replaces it with a new Statement of Principles concerning carpal tunnel syndrome under the Veterans’ Entitlements Act 1986. This Statement of Principles pertains to carpal tunnel syndrome, which is defined as an entrapment neuropathy of the median nerve at the wrist, and death from carpal tunnel syndrome, where such death is contributed to by the syndrome. The new Statement of Principles applies to all matters to which section 120B of the Act applies, effectively extending its application to veterans and members of the Forces who claim that their carpal tunnel syndrome or death from it is connected with their relevant service. To establish such a connection, certain factors must exist, such as performing repetitive or forceful activities with the affected hand, daily self-propulsion of a manual wheelchair, exposure to direct vibration of the affected hand or forearm, or suffering from specific injuries or conditions affecting the wrist or hand. The instrument also outlines definitions for various terms used in the Statement of Principles and specifies that certain factors apply only to material contribution to, or aggravation of, carpal tunnel syndrome where the condition was suffered or contracted before or during the relevant service. The instrument's scope is national, affecting all veterans and members of the Forces within Australia who may claim under the Veterans' Entitlements Act.

Key Provisions

The Legislative Instrument, numbered 90 of 2001, pertains to the revocation and determination of a Statement of Principles concerning carpal tunnel syndrome (section 1). The Repatriation Medical Authority, under section 196B(3) of the Veterans’ Entitlements Act 1986, revokes Instrument No. 72 of 1997 and determines in its place a new Statement of Principles regarding carpal tunnel syndrome and death from carpal tunnel syndrome (section 1(a) and (b)). The Statement of Principles identifies carpal tunnel syndrome as an entrapment neuropathy of the median nerve at the wrist, producing altered sensation, pain, or weakness of the hand, with ICD-10-AM code G56.0 (section 2(a) and (b)). The Authority bases its determination on available medical-scientific evidence, holding the view that carpal tunnel syndrome and death from carpal tunnel syndrome can be related to relevant service rendered by veterans or members of the Forces (section 3). The Act imposes several obligations on parties governed by it, primarily relating to the identification and substantiation of factors that link carpal tunnel syndrome to relevant service (section 4). For carpal tunnel syndrome or death from carpal tunnel syndrome to be connected with service, at least one of the specified factors must be related to the service. These factors include performing repetitive or forceful activities with the affected hand, daily self-propulsion of a manual wheelchair, direct vibration of the hand or forearm, injuries or surgeries to the wrist or hand, certain medical conditions, and failure to obtain appropriate clinical management (section 5). Additionally, certain factors only apply to material contribution or aggravation of carpal tunnel syndrome if the syndrome was suffered or contracted before or during service (section 6). The Act does not explicitly mention offences, penalties, or consequences for breaches. However, failure to comply with the provisions or providing false information could potentially lead to administrative penalties or denial of entitlements under the Veterans’ Entitlements Act 1986. The maximum penalties for providing false information in the context of veterans' entitlements could include fines or imprisonment, although specific penalties would be determined under the relevant sections of the primary Act or other applicable legislation.

Legal classification tags

Area of Law
Veterans’ Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Regulatory Standards

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.